cystic fibrosis

Vertex's Cystic Fibrosis Combo Gets Priority Review in U.S.
Vertex's Cystic Fibrosis Combo Gets Priority Review in U.S.
Yahoo/Zacks.com
Vertex Pharmaceuticals
cystic fibrosis
FDA
priority review
EMA
tezacaftor/ivacaftor
Kalydeco
Flag link:
Vertex wins new Kalydeco approval, ups sales forecast
Vertex wins new Kalydeco approval, ups sales forecast
BioPharma Dive
Vertex Pharmaceuticals
Kalydeco
cystic fibrosis
Flag link:
Vertex set up for CF monopoly due to data, contracts
Vertex set up for CF monopoly due to data, contracts
BioPharma Dive
Vertex Pharmaceuticals
cystic fibrosis
Flag link:
Biotech Stocks on Fire After Vertex News
Biotech Stocks on Fire After Vertex News
Investopedia
biotech
Vertex Pharmaceuticals
cystic fibrosis
Flag link:
'Just What We Dreamed.' New Vertex Drugs Show Dramatic Benefit Against Cystic Fibrosis
'Just What We Dreamed.' New Vertex Drugs Show Dramatic Benefit Against Cystic Fibrosis
Forbes
Vertex Pharmaceuticals
cystic fibrosis
Orkambi
Kalydeco
Flag link:
Is Vertex Pharmaceuticals Running Out of Steam or Taking a Breather?
Is Vertex Pharmaceuticals Running Out of Steam or Taking a Breather?
Motley Fool
Vertex Pharmaceuticals
cystic fibrosis
Flag link:
Inside Vertex Pharmaceuticals’ Clinical Pipeline
Inside Vertex Pharmaceuticals’ Clinical Pipeline
Market Realist
Vertex Pharmaceuticals
Tezacaftor-Ivacaftor
cystic fibrosis
Flag link:
FDA Details How Kalydeco's Indication Expanded Without New Clinical Data
FDA Details How Kalydeco's Indication Expanded Without New Clinical Data
RAPS.org
FDA
Kalydeco
cystic fibrosis
Flag link:
Corbus drug aces second mid-stage trial, this time in cystic fibrosis
Corbus drug aces second mid-stage trial, this time in cystic fibrosis
Bizjournals.com
Corbus Pharmaceuticals
clinical trials
cystic fibrosis
anabasum
Flag link:
Vertex Pharma shares jump more than 20% on cystic fibrosis study results
Vertex Pharma shares jump more than 20% on cystic fibrosis study results
Marketwatch
Vertex Pharmaceuticals
cystic fibrosis
tezacaftor
Kalydeco
clinical trials
Flag link:
A Review Of Concert's Filed PRE 14A: The CTP-656 Saga May Not Be Done Yet
A Review Of Concert's Filed PRE 14A: The CTP-656 Saga May Not Be Done Yet
Seeking Alpha
Concert Pharmaceuticals
CTP-656
cystic fibrosis
Kalydeco
Vertex Pharmaceuticals
Flag link:
Concert rebuffed $250M buyout offer from Vertex before CF drug deal
Concert rebuffed $250M buyout offer from Vertex before CF drug deal
Bizjournals.com
Concert Pharmaceuticals
Vertex Pharmaceuticals
M&A
cystic fibrosis
CTP-656
Kalydeco
Flag link:
Vertex Pharma Acquires Long-Acting Version of Cystic Fibrosis Drug From Concert Pharma
Vertex Pharma Acquires Long-Acting Version of Cystic Fibrosis Drug From Concert Pharma
TheStreet.com
Vertex Pharma
cystic fibrosis
Concert Pharmaceuticals
CTP-656
Kalydeco
Flag link:
Bad News Biotechs: What's Next for Juno and PTC Therapeutics?
Bad News Biotechs: What's Next for Juno and PTC Therapeutics?
Motley Fool
Juno Therapeutics
PTC Therapeutics
CAR-T
Celgene
cystic fibrosis
Translarna
Flag link:
5 Ways Vertex Pharmaceuticals Plans to Grow in 2017 and Beyond
5 Ways Vertex Pharmaceuticals Plans to Grow in 2017 and Beyond
Motley Fool
Vertex Pharmaceuticals
JPMHC 2017
cystic fibrosis
Flag link:
​Vertex sales prediction for top-selling drug lower than hoped
​Vertex sales prediction for top-selling drug lower than hoped
Bizjournals.com
Vertex Pharmaceuticals
Orkambi
cystic fibrosis
JPMHC 2017
Flag link:
Colorado biotech to streamline operations, explore alternatives after clinical trial failure
Colorado biotech to streamline operations, explore alternatives after clinical trial failure
Bizjournals.com
Nivalis
Colorado
biotech
layoffs
clinical trials
cavosonstat
cystic fibrosis
N3
Flag link:
Cystic Fibrosis Strategy: Will It Boost Vertex’s Future Revenues?
Cystic Fibrosis Strategy: Will It Boost Vertex’s Future Revenues?
Market Realist
Vertex Pharmaceuticals
cystic fibrosis
Orkambi
Kalydeco
Flag link:
Anthera sees 64% of its value wiped off as CF candidate flunks phase 3 test
Anthera sees 64% of its value wiped off as CF candidate flunks phase 3 test
Fierce Biotech
Anthera
clinical trials
cystic fibrosis
Sollpura
Flag link:
Galapagos, AbbVie glimpse early progress in search of a cystic fibrosis triple to rival Vertex
Galapagos, AbbVie glimpse early progress in search of a cystic fibrosis triple to rival Vertex
Endpoints
Galapagos
AbbVie
Vertex Pharmaceuticals
cystic fibrosis
GLPG1837
Flag link: